A Novel Filter-Based Distal Embolic Protection Device for Percutaneous Intervention of Saphenous Vein Graft LesionsResults of the AMEthyst Randomized Controlled Trial
Dean J. Kereiakes, MD, FACC*,*,
Mark A. Turco, MD, FACC ,
Jeffrey Breall, MD, PhD ,
Naim Z. Farhat, MD ,
Robert L. Feldman, MD¶,
Brent McLaurin, MD||,
Jeffrey J. Popma, MD, FACC**,
Laura Mauri, MD, MSc**, ,
Peter Zimetbaum, MD , ,
Joseph Massaro, PhD ,
Donald E. Cutlip, MD , on behalf of the AMEthyst Study Investigators
* The Christ Hospital Heart and Vascular Center and the Lindner Research Center, Cincinnati, Ohio
Center for Cardiac & Vascular Research, Washington Adventist Hospital, Takoma Park, Maryland
Krannert Institute of Cardiology, Indiana University of Medicine, Indianapolis, Indiana
North Ohio Heart Center, Elyria, Ohio
¶ Munroe Regional Medical Center, Ocala, Florida
|| Anderson Area Medical Center, Anderson, South Carolina
** Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts
 Harvard Clinical Research Institute, Boston, Massachusetts
 Beth Israel Deaconess Medical Center, Boston, Massachusetts.

View larger version (49K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Interceptor PLUS Coronary Filter System
Components of the Interceptor PLUS Coronary Filter System include: (A) actuator handle for filter deployment and closure; (B) low profile (2.7-F) of the undeployed filter on a 0.014-inch wire; and (C) expanded filter with 1,400- to 1,800-µm proximal in-flow openings (large arrow) and 100-µm distal pores (small arrow).
|
|

View larger version (90K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Comparison of Filter Open-Pore Areas
Scanning electron microscopy of expanded (A) FilterWire EZ and (B) Interceptor PLUS devices. The open-pore area of the Interceptor PLUS exceeds that of the FilterWire EZ (71% vs. 27%, respectively) and results in greater relative flow (60%) measured in vitro.
|
|
|